Filing Flows › Cardiff Oncology (CRDF) › How it makes money
How Cardiff Oncology (CRDF) makes money
Cardiff Oncology (CRDF) made $104K of revenue in the second quarter 2026 (Q2 2026), -14% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $104K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $104K | -14% |
| Q1 2026 | $41K | -62% |
| Q4 2025 | $243K | +61% |
| Q3 2025 | $120K | -27% |
| Q2 2025 | $121K | -26% |
| Q1 2025 | $109K | -47% |
| Q4 2024 | $151K | -3% |
From Cardiff Oncology's 10-Q filed Aug 11, 2026 (on EDGAR).
Questions
How does Cardiff Oncology make money?
Cardiff Oncology (CRDF) made $104K of revenue in the second quarter 2026 (Q2 2026), -14% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.